Genmab price target lowered to DKK 2,250 from DKK 2,500 at Deutsche Bank
The Fly

Genmab price target lowered to DKK 2,250 from DKK 2,500 at Deutsche Bank

Deutsche Bank lowered the firm’s price target on Genmab (GMAB) to DKK 2,250 from DKK 2,500 and keeps a Buy rating on the shares.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App